chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: PNC15
Symptoms: Expired product administered, No adverse event
Clinical narrative: no adverse event; Inbound call transferred from specialist received. called to report expired administered VAXNEUVANCE. Caller was on delayed hold while sought guidance; agreed to returned call with additional guidance for expired administered vaccine. ; This spontaneous report was received from a nurse referring to an unknown age and gender patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 30-MAY-2023, the patient started therapy with pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) injection, 1 dose, lot #U036156, expiration date: 25-MAY-2023, administered for prophylaxis (strength, and route of administration were not provided) (Expired product administered).  No additional adverse event (AE) or product quality compliant (PQC). Inbound call transferred from specialist received and called to report that expired administered pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE). Caller was on delayed hold while employee sought guidance; agreed to returned call with additional guidance for expired administered vaccine. Complete AE details not received at the reporting time.  The causality between the event and pneumococcal 15v conj vaccine (crm197) (VAXNEUVANCE) was not reported.
Age: 0.58
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received vaccine which had been punctured for more than 12 hours; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine which had been punctured for more than 12 hours) and NO ADVERSE EVENT (No adverse event) in a 7-month-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7184B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Jul-2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 11-Jul-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine which had been punctured for more than 12 hours) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine which had been punctured for more than 12 hours) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient received vaccine which had been punctured for more than 12 hours).    No concomitant medication was reported.  The date vial was first puncture on 10-JUL-2023. No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-733068 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-733068:Same reporter
Age: 12.0
Sex: M
Vaccine: MEN
Symptoms: Inappropriate schedule of product administration, Medication error, No adverse event, Wrong product administered
Clinical narrative: he was scheduled to receive a tdap, administering nurse gave him another meningococcal vaccine, which is confirmed to be MENQUADFI with no reported adverse event; menquadfi dose administered too early given 8 months apart with no reported adverse event; Initial information received on 12-Jul-2023 regarding an unsolicited valid non-serious case received from a consumer.  This case involves a 12 years old male patient who was scheduled to receive a tdap, administering nurse gave him another meningococcal vaccine, which is confirmed to be meningococcal A-C-Y-W135 (T CONJ) vaccine [Menquadfi] with no reported adverse event and menquadfi dose administered too early given 8 months apart with no reported adverse event.  The patient's past vaccination(s) included meningococcal vaccine on 17-Nov-2022. The patient's past medical history, medical treatment(s) and family history were not provided.  On 11-Jul-2023, the patient received an unknown dose of suspect meningococcal A-C-Y-W135 (T CONJ) vaccine, solution for injection (batch number: U7633AB) (expiry date unknown) via intramuscular route in the left deltoid for immunization while he was scheduled to receive a tdap and dose administered too early given 8 months apart with no reported adverse event (wrong product administered) (inappropriate schedule of product administration) (same day latency).  Action taken: not applicable.  At time of reporting, the outcome was Unknown for both the events.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 63.0
Sex: M
Vaccine: UNK
Symptoms: Aphonia, Bacterial infection, Fatigue, Headache, Heart rate irregular
Clinical narrative: Paralysis, extreme fatigue, insomnia, bacterial infection, Irregular heartbeat, headache, loss of voice
Age: 63.0
Sex: M
Vaccine: UNK
Symptoms: Insomnia, Paralysis
Clinical narrative: Paralysis, extreme fatigue, insomnia, bacterial infection, Irregular heartbeat, headache, loss of voice
Age: 20.0
Sex: M
Vaccine: ANTH
Symptoms: Injected limb mobility decreased, Injection site pain, Peripheral swelling
Clinical narrative: Patient received Anthrax vaccine Lot FAV256 prior to deployment at health clinic. The next day, left arm was swollen and unable to move with pain around injection site.
Age: 20.0
Sex: M
Vaccine: SMALL
Symptoms: Discomfort, Pruritus, Scab
Clinical narrative: 9 Month following vaccination in left arm, the smallpox scab area erupted again resulting in itching and discomfort.
Age: 22.0
Sex: M
Vaccine: HPV9
Symptoms: Abdominal pain, Arthralgia, Biliary colic, Lethargy
Clinical narrative: Client, following vaccination had crushing pain in Retroperitoneum region the following evening, joint pain in elbows and hands and lethargy. 6 months later gallbladder pain started despite having no risk factors. Joint pain and gallbladder issues continue to this day.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Abdominal discomfort, Dizziness, Fatigue, Hypersomnia, Pain in extremity
Clinical narrative: extreme fatigue, stomach upset, sore arm, could not sleep on that side. achy body, dizziness, so tired, that I needed to sleep most of day the 2nd day. this lasted until the morning of the 3rd day (Friday).
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Sleep disorder
Clinical narrative: extreme fatigue, stomach upset, sore arm, could not sleep on that side. achy body, dizziness, so tired, that I needed to sleep most of day the 2nd day. this lasted until the morning of the 3rd day (Friday).
Sex: U
Vaccine: MMRV
Symptoms: No adverse event, Product storage error
Clinical narrative: No additional AE/PQC; improperly stored PROQUAD that was inadvertently administered to a patient; This spontaneous report was received from a nurse and refers to a unspecified age and gender patient whose medical history, concurrent conditions, and concomitant therapies were not reported.  On 15-JUN-2023, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin, rHA) (PROQUAD) subcutaneous injection, administered for prophylaxis at a dose of 0.5 milliliters (ml) (lot number: W023867, which was determined to be valid with expiration date: 24-JAN-2024; strength, anatomical injection site, and route of administration were not provided) (product storage error).  No additional adverse events (AE) were reported (no adverse event).
Age: 0.33
Sex: M
Vaccine: DTAP
Symptoms: Expired product administered
Clinical narrative: administration of an expired Infanrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 4-month-old male patient who received DTPa (Infanrix) (batch number 7KM94, expiry date 10-JUN-2023) for prophylaxis.   On 12-JUL-2023, the patient received Infanrix. On 12-JUL-2023, an unknown time after receiving Infanrix, the patient experienced expired vaccine used (Verbatim: administration of an expired Infanrix). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt date: 12-JUL-2023 The reporter was a medical assistant. The reporter reported that a patient received an expired Infanrix dose which led to expired vaccine used. The reporter wanted to know if the patient had to be revaccinated.  The reporter did not consent to follow-up.
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; Expired product administered (5 adult patients received expired booster doses of Bivalent Moderna COVID-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired product administered (5 adult patients received expired booster doses of Bivalent Moderna COVID-19 vaccine) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 022H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 07-Jul-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 07-Jul-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired product administered (5 adult patients received expired booster doses of Bivalent Moderna COVID-19 vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired product administered (5 adult patients received expired booster doses of Bivalent Moderna COVID-19 vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired product administered (5 adult patients received expired booster doses of Bivalent Moderna COVID-19 vaccine).    Concomitant product use was not provided by the reporter.  Suspect vaccine was Bivalent BA.4-5 Blue Cap. It was reported that suspect vaccine might administer on another date in Jun-2023. Vial size was 2.5 ml. Vial was initially stored in the refrigerator on 07-Jul-2023 which was less then 30 days of administration of vaccine. Vial did not undergo any temperature excursions. Expiry date was reported as 01-Jun-2023. Dosage text was reported as unknown.  Treatment information was not provided.  This case contains information about patient 2nd out of 5 adult patients.   This case was linked to US-MODERNATX, INC.-MOD-2023-732775 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-732775:Master case
Sex: F
Vaccine: COVID19-2
Symptoms: Nasopharyngitis
Clinical narrative: Cold; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Cold) in an elderly female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 060F22A) for COVID-19 prophylaxis.     Concurrent medical conditions included Immunocompromised.    On 04-Nov-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In July 2023, the patient experienced NASOPHARYNGITIS (Cold). At the time of the report, NASOPHARYNGITIS (Cold) had not resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication not reported.   She had been taking a cold and flu thing. She had also been taking zycan. Never had covid in the past.
Age: 2.0
Sex: U
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: No adverse event; HCP advised that her office administered 3 vaccinations with expired vaccines; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (HCP advised that her office administered 3 vaccinations with expired vaccines) and NO ADVERSE EVENT (No adverse event) in a 2-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 069H22A) for COVID-19 prophylaxis.     Question:Describe relevant medical history/conditions, allergy, concomitant diseases and risk factor.Answer:Unknown.     On 12-Jul-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 12-Jul-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (HCP advised that her office administered 3 vaccinations with expired vaccines). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (HCP advised that her office administered 3 vaccinations with expired vaccines) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (HCP advised that her office administered 3 vaccinations with expired vaccines).    It was unknown whether the patient had received any other vaccines in the 4 weeks prior to COVID-19 vaccine or not. Concomitant medication details not reported by the reporter. Suspect product dosage text was reported as unknown. The expiry date was reported as 18-JUN-2023. Treatment details was not reported by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-733038 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-733038:Same reporter
Age: 0.33
Sex: F
Vaccine: UNK
Symptoms: Medication error, No adverse event, Single component of a two-component product administered
Clinical narrative: administered PENTACEL without the ACT-HIB component with no reported adverse event; Initial information received on 12-Jul-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case is linked to case 2023SA210789.  This case involves a 4 months old female patient who was administered diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (VERO)] without the act-hib component with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included rotavirus vaccine live reassort oral 5V (Rotateq) and pneumococcal vaccine CONJ 15V (CRM197) (Vaxneuvance) both for prophylactic vaccination (Immunisation).  On 06-Jul-2023, the patient received a dose of 0.5 ml (dose 2) once of suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine (Suspension for injection) (lot: UJ868AA; expiry date: 30-Mar-2024; strength: standard) via intramuscular route in the right thigh for Immunization.  On 06-Jul-2023 the patient was administered pentacel without the act-hib component with no reported adverse event (single component of a two-component product administered) (latency: same day).  It was reported, "HCP already know what to do but they have not administered the ACT-HIB component since they don't have the diluent for the vaccine. HCP was warm transferred to the Pasteur Customer Service for their order of the ACT-HIB diluent."   Action taken was not applicable.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 28.0
Sex: F
Vaccine: HEP
Symptoms: Unevaluable event
Clinical narrative: None, vaccination error
Age: 56.0
Sex: F
Vaccine: TDAP
Symptoms: Chills, Malaise, Myalgia, Sensitive skin
Clinical narrative: 56 yo woman Received t-dap booster on 6/26/2023 from PCP wellness appointment. Side effects have not subsided since receiving vaccine which include muscle, soreness, skin sensitivity all over body, especially down the back, chills, overall malaise.
Age: 35.0
Sex: F
Vaccine: COVID19-2
Symptoms: Embolic stroke, Facial paresis, Symptom recurrence
Clinical narrative: ACUTE STROKE DUE TO EMBOLISM OF UNSPECIFIED ARTERY LEFT FACIAL MUSCLE WEAKNESS 1/9/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 0.33
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient received expired Pentacel vaccine during 4 month well child check. No adverse events occurred. Mother of child was notified and offered revaccination.
Age: 0.08
Sex: F
Vaccine: DTPPVHBHPB, PNC13, RV5, DTPPVHBHPB, PNC13, RV5
Symptoms: Decreased appetite, Infant irritability, Injection site erythema, Injection site rash, Injection site warmth
Clinical narrative: Parents state that about 2 or 3 hours after the vaccines this morning, they noticed that her legs from the upper thighs to the bottom of her feet were bright red and warm, did states that it was this way especially on the bottom of her feet.  This redness and warmth lasted for about 30 minutes.  They noticed the red dots on her lower legs shortly thereafter.  Parents report that other than the rash, she has been cranky and not wanting to eat.  A little better with Tylenol on board.  Still wetting diapers well.  She has had no difficulty breathing or swallowing. There is a petechial rash to bilateral lower legs which may be an abnormal reaction to the vaccines or possibly mechanical in etiology.  Exam is otherwise reassuring.  Will report to VAERS.  No need to amend future vaccine schedule.  Discussed possible etiologies today with parents.  Monitoring and red flags discussed in detail.
Age: 0.08
Sex: F
Vaccine: DTPPVHBHPB, PNC13, RV5, DTPPVHBHPB, PNC13, RV5
Symptoms: Petechiae, Rash erythematous
Clinical narrative: Parents state that about 2 or 3 hours after the vaccines this morning, they noticed that her legs from the upper thighs to the bottom of her feet were bright red and warm, did states that it was this way especially on the bottom of her feet.  This redness and warmth lasted for about 30 minutes.  They noticed the red dots on her lower legs shortly thereafter.  Parents report that other than the rash, she has been cranky and not wanting to eat.  A little better with Tylenol on board.  Still wetting diapers well.  She has had no difficulty breathing or swallowing. There is a petechial rash to bilateral lower legs which may be an abnormal reaction to the vaccines or possibly mechanical in etiology.  Exam is otherwise reassuring.  Will report to VAERS.  No need to amend future vaccine schedule.  Discussed possible etiologies today with parents.  Monitoring and red flags discussed in detail.
Age: 0.08
Sex: F
Vaccine: DTPPVHBHPB, PNC13, RV5, DTPPVHBHPB, PNC13, RV5
Symptoms: Food refusal, Irritability, Petechiae, Product use issue, Rash
Clinical narrative: Parents state that about 2 or 3 hours after the vaccines this morning, they noticed that her legs from the upper thighs to the bottom of her feet were bright red and warm, did states that it was this way especially on the bottom of her feet.  This redness and warmth lasted for about 30 minutes.  They noticed the red dots on her lower legs shortly thereafter.  Parents report that other than the rash, she has been cranky and not wanting to eat.  A little better with Tylenol on board.  Still wetting diapers well.  She has had no difficulty breathing or swallowing. There is a petechial rash to bilateral lower legs which may be an abnormal reaction to the vaccines or possibly mechanical in etiology.  Exam is otherwise reassuring.  Will report to VAERS.  No need to amend future vaccine schedule.  Discussed possible etiologies today with parents.  Monitoring and red flags discussed in detail.
Age: 0.08
Sex: F
Vaccine: DTPPVHBHPB, PNC13, RV5, DTPPVHBHPB, PNC13, RV5
Symptoms: Skin warm
Clinical narrative: Parents state that about 2 or 3 hours after the vaccines this morning, they noticed that her legs from the upper thighs to the bottom of her feet were bright red and warm, did states that it was this way especially on the bottom of her feet.  This redness and warmth lasted for about 30 minutes.  They noticed the red dots on her lower legs shortly thereafter.  Parents report that other than the rash, she has been cranky and not wanting to eat.  A little better with Tylenol on board.  Still wetting diapers well.  She has had no difficulty breathing or swallowing. There is a petechial rash to bilateral lower legs which may be an abnormal reaction to the vaccines or possibly mechanical in etiology.  Exam is otherwise reassuring.  Will report to VAERS.  No need to amend future vaccine schedule.  Discussed possible etiologies today with parents.  Monitoring and red flags discussed in detail.
Age: 80.0
Sex: M
Vaccine: COVID19-2
Symptoms: Bell's palsy, Facial paresis
Clinical narrative: RIGHT BELLS PALSY RIGHT FACIAL MUSCLE WEAKNESS
Age: 77.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hypotension, Transient ischaemic attack
Clinical narrative: TRANSIENT CEREBRAL ISCHEMIA 3/12/2023  --  HYPOTENSION
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Anticoagulant therapy, COVID-19, Cardiac failure congestive, Faeces discoloured
Clinical narrative: "Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures) the patient presented with leg edema found to be in CHF, diuresed. On admission she was also found to be anemic, reported melena. Transfused and treated empirically with PPI - GI said she was too high risk for endoscopy. Stools became brown and hgb stabilized. Tolerated resumption of anticoagulation. Risk > benefit regarding endoscopy I agree. Loaded with venofer. During stay developed respiratory insufficiency fever and leukocytosis treated with zosyn -- > levaquin for HOSPITAL ACQUIRED PNEUMONIA. On discharge tested positive for covid but no longer needing oxygen."
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Leukocytosis, Melaena, Oedema peripheral, Pneumonia, Polyuria
Clinical narrative: "Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures) the patient presented with leg edema found to be in CHF, diuresed. On admission she was also found to be anemic, reported melena. Transfused and treated empirically with PPI - GI said she was too high risk for endoscopy. Stools became brown and hgb stabilized. Tolerated resumption of anticoagulation. Risk > benefit regarding endoscopy I agree. Loaded with venofer. During stay developed respiratory insufficiency fever and leukocytosis treated with zosyn -- > levaquin for HOSPITAL ACQUIRED PNEUMONIA. On discharge tested positive for covid but no longer needing oxygen."
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Respiratory failure, SARS-CoV-2 test negative, SARS-CoV-2 test positive
Clinical narrative: "Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures) the patient presented with leg edema found to be in CHF, diuresed. On admission she was also found to be anemic, reported melena. Transfused and treated empirically with PPI - GI said she was too high risk for endoscopy. Stools became brown and hgb stabilized. Tolerated resumption of anticoagulation. Risk > benefit regarding endoscopy I agree. Loaded with venofer. During stay developed respiratory insufficiency fever and leukocytosis treated with zosyn -- > levaquin for HOSPITAL ACQUIRED PNEUMONIA. On discharge tested positive for covid but no longer needing oxygen."
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: VACCINE EXPIRED
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: expired vaccine
Age: 68.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hypoxia, Symptom recurrence
Clinical narrative: PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE HYPOXIA 1/14/2023,  1/10/2023,  1/19/2023,  1/9/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 11.0
Sex: M
Vaccine: HPV9, MENB, MNQ, TDAP
Symptoms: Wrong product administered
Clinical narrative: Menquadfi was ordered at pt's office visit on 7/14/23, but pt was given Trumenba in error.  Correct vaccine (Menquadfi) was then administered.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site rash, Injection site warmth, Rash erythematous, Rash papular
Clinical narrative: slightly raised rash around site of injection; red and warm 4" x 2" began ~ 3 days after injection and persisting 10 days after injection
Age: 33.0
Sex: F
Vaccine: HEPA
Symptoms: Underdose
Clinical narrative: The patient is 33 years old and she got a Hep A vaccine for a child. Wrong age group vaccine given.
Age: 43.0
Sex: F
Vaccine: HEPAB
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient given 3rd dose too soon.
Age: 0.17
Sex: F
Vaccine: DTAPIPV
Symptoms: No adverse event, Wrong product administered
Clinical narrative: DTaP was ordered, Quadracel was given. Patient had no adverse reaction.
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Anticoagulant therapy, Atrial fibrillation, Blood lactic acid
Clinical narrative: Patient is a 81 y.o. female patient of, DO with history of CAD, PSVT, HTN, HLD, hypothyroidism, kidney stones presented to Hospital with cough, shortness of breath. She was found to COVID, acute respiratory failure needing 10 L O2 and atrial fibrillation with RVR.   Acute Hypoxemic Respiratory Failure Secondary to viral pneumonia likely from COVID CXR with left mid lung patchy opacities CTA PE with no PE, multifocal irregular nodular infiltrates in the LUL and LLL Strep pneumo/legionella Ags negative; stop CTX/Azithro Requiring 10L on admission, weaned to room air 5/15   Sepsis COVID-19 virus infection Date of onset of symptoms: 5/5 Symptoms present on admission: productive  Symptoms present on admission: productive cough, shortness of breath Date of covid positive test: 5/11 Vaccination status: vaccinated with updated bivalent booster Imaging: CXR as above with left sided mid lung opacities; CTA as above Oxygen requirements on admission: 10L Pulmonology briefly followed, s/p Remdesivir x4 days and Decadron until weaned to room air   Atrial fibrillation with RVR In setting of respiratory failure, pneumonia Prior episode of atrial fibrillation in February briefly EKG with atrial fibrillation with RVR on admission with HR 167 CHA2DS2-VASc of 4; eliquis initiated TTE in Feb with normal LVEF, though decreased RV function Diltiazem drip started on arrival and stopped 5/14 HR remains elevated, unable to wean cardizem Change home metoprolol to Toprol XL, 50mg BID Cardiology followed; added digoxin daily To follow up with Dr. (Cardiology) as outpatient   Lactic acidosis Lactate 2.1 on presentation Improved to 1.2 with treatment of hypoxia   CAD Per history, continue home ASA and statin   HTN On amlodipine and metoprolol at home Continue metoprolol as above, will stop amlodipine to allow titration of rate controlling medications   Hypothyroidism TSH 1.28 Continue home levothyroxine
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood thyroid stimulating hormone, CHA2DS2-VASc-score, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal
Clinical narrative: Patient is a 81 y.o. female patient of, DO with history of CAD, PSVT, HTN, HLD, hypothyroidism, kidney stones presented to Hospital with cough, shortness of breath. She was found to COVID, acute respiratory failure needing 10 L O2 and atrial fibrillation with RVR.   Acute Hypoxemic Respiratory Failure Secondary to viral pneumonia likely from COVID CXR with left mid lung patchy opacities CTA PE with no PE, multifocal irregular nodular infiltrates in the LUL and LLL Strep pneumo/legionella Ags negative; stop CTX/Azithro Requiring 10L on admission, weaned to room air 5/15   Sepsis COVID-19 virus infection Date of onset of symptoms: 5/5 Symptoms present on admission: productive  Symptoms present on admission: productive cough, shortness of breath Date of covid positive test: 5/11 Vaccination status: vaccinated with updated bivalent booster Imaging: CXR as above with left sided mid lung opacities; CTA as above Oxygen requirements on admission: 10L Pulmonology briefly followed, s/p Remdesivir x4 days and Decadron until weaned to room air   Atrial fibrillation with RVR In setting of respiratory failure, pneumonia Prior episode of atrial fibrillation in February briefly EKG with atrial fibrillation with RVR on admission with HR 167 CHA2DS2-VASc of 4; eliquis initiated TTE in Feb with normal LVEF, though decreased RV function Diltiazem drip started on arrival and stopped 5/14 HR remains elevated, unable to wean cardizem Change home metoprolol to Toprol XL, 50mg BID Cardiology followed; added digoxin daily To follow up with Dr. (Cardiology) as outpatient   Lactic acidosis Lactate 2.1 on presentation Improved to 1.2 with treatment of hypoxia   CAD Per history, continue home ASA and statin   HTN On amlodipine and metoprolol at home Continue metoprolol as above, will stop amlodipine to allow titration of rate controlling medications   Hypothyroidism TSH 1.28 Continue home levothyroxine
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cough, Dyspnoea, Electrocardiogram abnormal, Heart rate increased, Hypertension
Clinical narrative: Patient is a 81 y.o. female patient of, DO with history of CAD, PSVT, HTN, HLD, hypothyroidism, kidney stones presented to Hospital with cough, shortness of breath. She was found to COVID, acute respiratory failure needing 10 L O2 and atrial fibrillation with RVR.   Acute Hypoxemic Respiratory Failure Secondary to viral pneumonia likely from COVID CXR with left mid lung patchy opacities CTA PE with no PE, multifocal irregular nodular infiltrates in the LUL and LLL Strep pneumo/legionella Ags negative; stop CTX/Azithro Requiring 10L on admission, weaned to room air 5/15   Sepsis COVID-19 virus infection Date of onset of symptoms: 5/5 Symptoms present on admission: productive  Symptoms present on admission: productive cough, shortness of breath Date of covid positive test: 5/11 Vaccination status: vaccinated with updated bivalent booster Imaging: CXR as above with left sided mid lung opacities; CTA as above Oxygen requirements on admission: 10L Pulmonology briefly followed, s/p Remdesivir x4 days and Decadron until weaned to room air   Atrial fibrillation with RVR In setting of respiratory failure, pneumonia Prior episode of atrial fibrillation in February briefly EKG with atrial fibrillation with RVR on admission with HR 167 CHA2DS2-VASc of 4; eliquis initiated TTE in Feb with normal LVEF, though decreased RV function Diltiazem drip started on arrival and stopped 5/14 HR remains elevated, unable to wean cardizem Change home metoprolol to Toprol XL, 50mg BID Cardiology followed; added digoxin daily To follow up with Dr. (Cardiology) as outpatient   Lactic acidosis Lactate 2.1 on presentation Improved to 1.2 with treatment of hypoxia   CAD Per history, continue home ASA and statin   HTN On amlodipine and metoprolol at home Continue metoprolol as above, will stop amlodipine to allow titration of rate controlling medications   Hypothyroidism TSH 1.28 Continue home levothyroxine
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypothyroidism, Lactic acidosis, Legionella test, Lung opacity, Pneumonia
Clinical narrative: Patient is a 81 y.o. female patient of, DO with history of CAD, PSVT, HTN, HLD, hypothyroidism, kidney stones presented to Hospital with cough, shortness of breath. She was found to COVID, acute respiratory failure needing 10 L O2 and atrial fibrillation with RVR.   Acute Hypoxemic Respiratory Failure Secondary to viral pneumonia likely from COVID CXR with left mid lung patchy opacities CTA PE with no PE, multifocal irregular nodular infiltrates in the LUL and LLL Strep pneumo/legionella Ags negative; stop CTX/Azithro Requiring 10L on admission, weaned to room air 5/15   Sepsis COVID-19 virus infection Date of onset of symptoms: 5/5 Symptoms present on admission: productive  Symptoms present on admission: productive cough, shortness of breath Date of covid positive test: 5/11 Vaccination status: vaccinated with updated bivalent booster Imaging: CXR as above with left sided mid lung opacities; CTA as above Oxygen requirements on admission: 10L Pulmonology briefly followed, s/p Remdesivir x4 days and Decadron until weaned to room air   Atrial fibrillation with RVR In setting of respiratory failure, pneumonia Prior episode of atrial fibrillation in February briefly EKG with atrial fibrillation with RVR on admission with HR 167 CHA2DS2-VASc of 4; eliquis initiated TTE in Feb with normal LVEF, though decreased RV function Diltiazem drip started on arrival and stopped 5/14 HR remains elevated, unable to wean cardizem Change home metoprolol to Toprol XL, 50mg BID Cardiology followed; added digoxin daily To follow up with Dr. (Cardiology) as outpatient   Lactic acidosis Lactate 2.1 on presentation Improved to 1.2 with treatment of hypoxia   CAD Per history, continue home ASA and statin   HTN On amlodipine and metoprolol at home Continue metoprolol as above, will stop amlodipine to allow titration of rate controlling medications   Hypothyroidism TSH 1.28 Continue home levothyroxine
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pneumonia viral, Right ventricular ejection fraction decreased, Sepsis
Clinical narrative: Patient is a 81 y.o. female patient of, DO with history of CAD, PSVT, HTN, HLD, hypothyroidism, kidney stones presented to Hospital with cough, shortness of breath. She was found to COVID, acute respiratory failure needing 10 L O2 and atrial fibrillation with RVR.   Acute Hypoxemic Respiratory Failure Secondary to viral pneumonia likely from COVID CXR with left mid lung patchy opacities CTA PE with no PE, multifocal irregular nodular infiltrates in the LUL and LLL Strep pneumo/legionella Ags negative; stop CTX/Azithro Requiring 10L on admission, weaned to room air 5/15   Sepsis COVID-19 virus infection Date of onset of symptoms: 5/5 Symptoms present on admission: productive  Symptoms present on admission: productive cough, shortness of breath Date of covid positive test: 5/11 Vaccination status: vaccinated with updated bivalent booster Imaging: CXR as above with left sided mid lung opacities; CTA as above Oxygen requirements on admission: 10L Pulmonology briefly followed, s/p Remdesivir x4 days and Decadron until weaned to room air   Atrial fibrillation with RVR In setting of respiratory failure, pneumonia Prior episode of atrial fibrillation in February briefly EKG with atrial fibrillation with RVR on admission with HR 167 CHA2DS2-VASc of 4; eliquis initiated TTE in Feb with normal LVEF, though decreased RV function Diltiazem drip started on arrival and stopped 5/14 HR remains elevated, unable to wean cardizem Change home metoprolol to Toprol XL, 50mg BID Cardiology followed; added digoxin daily To follow up with Dr. (Cardiology) as outpatient   Lactic acidosis Lactate 2.1 on presentation Improved to 1.2 with treatment of hypoxia   CAD Per history, continue home ASA and statin   HTN On amlodipine and metoprolol at home Continue metoprolol as above, will stop amlodipine to allow titration of rate controlling medications   Hypothyroidism TSH 1.28 Continue home levothyroxine
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine expired due to tempurature
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine expired due to tempurature
Age: 7.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine expired due to tempurature
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Cholecystitis, Death, Hypoxic-ischaemic encephalopathy, Septic shock
Clinical narrative: The victim experienced  abdominal pain 3 days prior to death at hospital from septic shock cholecystits Anoxic encepathy from clotting in the lower intestine resulting in death.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Thrombosis
Clinical narrative: The victim experienced  abdominal pain 3 days prior to death at hospital from septic shock cholecystits Anoxic encepathy from clotting in the lower intestine resulting in death.
Age: 69.0
Sex: F
Vaccine: PNC20
Symptoms: Chills, Pain, Pyrexia
Clinical narrative: Subjective fever x3d, chills, body aches.  Sx's are resolving at this time.
Age: 6.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: vacccine expired due to tempurature
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: vaccine expired due to tempurature.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome, Vertigo positional
Clinical narrative: G47.33 OBSTRUCTIVE SLEEP APNEA 5/1/2023 BENIGN PAROXYSMAL POSITIONAL VERTIGO
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Ventricular tachycardia
Clinical narrative: HYPOTENSION 3/26/2023 VENTRICULAR TACHYCARDIA, UNSPECIFIED TYPE
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Metabolic encephalopathy
Clinical narrative: J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/17/2023 COVID-19 DISEASE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/17/2023 METABOLIC ENCEPHALOPATHY
Age: 77.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Hypoxia
Clinical narrative: ACUTE NON ST ELEVATION MI HYPOXIA
Age: 82.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cardiovascular insufficiency, Oxygen saturation abnormal
Clinical narrative: Blood circulation became very bad and affected oxygen delivered to brain
Age: 62.0
Sex: M
Vaccine: COVID19-2
Symptoms: Angina pectoris
Clinical narrative: ANGINA, UNSPECIFIED
Age: 2.67
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: Patient was given Pfizer-BioNTech Covid-19, Bivalent Original and Omicron BA.4/BA.5 for 6 months to <5yrs, LOT #GK1667 on 7/10/2023 as the second dose in series. The vaccine's beyond use date was 07/03/2023.
Age: 73.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Neuropathy peripheral, Respiratory failure, Symptom recurrence
Clinical narrative: PERIPHERAL NEUROPATHY ACUTE RESPIRATORY FAILURE ACUTE HYPERCAPNIC RESPIRATORY FAILURE 2/16/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: vaccine expired due to temp
Age: 87.0
Sex: F
Vaccine: VARZOS
Symptoms: Musculoskeletal disorder, Pain in extremity
Clinical narrative: After the vaccination, on Saturday morning, I woke up with an arm, that I could not use. It stayed sore until about mid afternoon, and it still hurts today. I am going to call the doctor to see if its something they can do. I have not been to the doctor yet.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Pruritus, Rash, Rash macular, Rash maculo-papular
Clinical narrative: Itchy lower left leg with macular papular rash. Rash the appeared on left arm and left leg. Rash continued to appear in blotches on upper thighs and arms and neck on right side. Calamine, Zyrtec, Benadryl, topical clobetasol and triamcinolone ointment and baking soda paste with no improvement. One day 8 urgent care visit that provide a kenalog injection and medrol dose pack. Continued taking Benadryl every 8 hours with slight relief. Epsom salts soak on day 9 provided some relief and decreased itching for several hours. Day 10 redness reduced substantially, and itching has reduced yet still present.
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE RESPIRATORY FAILURE, UNSPECIFIED ACUITY
Age: 39.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Symptom recurrence
Clinical narrative: ACUTE RESPIRATORY FAILURE 3/17/2023  &    2/1/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 8.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: expired vaccine due to temp
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: vaccine expired due to temp
Age: 9.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: vaccine expired due to tempurature
Age: 6.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: vaccine expired due to temp
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: vaccine expired due to tempurture
Age: 9.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: vaccine expired due to tempurature
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: vaccine expired due to temp
Age: 5.0
Sex: M
Vaccine: DTAP
Symptoms: Expired product administered
Clinical narrative: Vaccine given past it's expiration date of 3/1/2023
Age: 89.0
Sex: F
Vaccine: COVID19-2
Symptoms: Hypoxia
Clinical narrative: HYPOXIA
Age: 14.0
Sex: M
Vaccine: PPV
Symptoms: Abdominal discomfort, Headache, Rash
Clinical narrative: APPROX 24 HRS AFTER INJECTION PATIENT DEVELOPED RASH TO STOMACH, UPPER CHEST AND FACE. HIS EYES HURT, HAD A HEADACHE AND STOMACH WAS UPSET, THERE WAS NO TREATMENT GIVEN AT THIS TIME.  PATIENT'S ALLERGY DR ORDEREDFOR HIM TO HAVE THIS SO PARENTS STATED THAT THEY DIDN'T WANT TO TREAT HIM AS THEY WANTED HIS BODY TO BUILD THE IMMUNITY THEY JUST WERE REPORTING HIS REACTION.
Age: 0.33
Sex: F
Vaccine: DTAPHEPBIP
Symptoms: Abscess drainage, Abscess limb
Clinical narrative: This child tolerated 2m vaccines well and then with 4m vaccines developed thigh abscess, which was treated with bactrim with some improvement but recurred, then with 6m vaccines had the same reaction on the opposite leg. Concern for contaminated vaccines vs tampering with vaccine. Abscesses have now required drainage and IV antibiotics for resolution.
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain, Injection site pruritus, Injection site rash, Injection site warmth, Rash erythematous
Clinical narrative: Very tender left upper arm  Warm to touch  Large red maculopapular rash left upper arm Itchy
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash maculo-papular
Clinical narrative: Very tender left upper arm  Warm to touch  Large red maculopapular rash left upper arm Itchy
Age: 73.0
Sex: F
Vaccine: VARZOS
Symptoms: Dizziness, Dyspnoea, Nausea, Syncope, Vomiting
Clinical narrative: Patient reported prior to receiving vaccine that she occasionally gets lightheaded after vaccines but has tolerate many vaccines recently. The only time she reported syncope was during childhood, so we chose to administer vaccine but monitor closely. She reported no symptoms immediately after receiving the Shingrix, so I asked if she wanted to remain seated in the consultation room or move to a seat in our waiting room. She elected to go sit in our waiting room for about 10 minutes. Then, she mentioned to us that she was feeling a bit lightheaded, so I walked over next to her. She then fainted while sitting upright. She did not fall out of the chair. Her breathing became irregular, so I requested a staff member call EMS. I located a pulse and continued to attempt to wake her up. After approximately 30-45 seconds she awoke to full consciousness and began speaking normally. She said she was nauseous and vomitted. EMS arrived and she was feeling well. They walked her out to her car.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cardiac monitoring, Cardiac stress test, Chest X-ray, Disturbance in attention, Dizziness
Clinical narrative: Fainting, blackouts,( stroke symptom of left  eye blackout) , fatigue, dizziness,  inability to focus , headaches
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Laboratory test, Loss of consciousness, Magnetic resonance imaging
Clinical narrative: Fainting, blackouts,( stroke symptom of left  eye blackout) , fatigue, dizziness,  inability to focus , headaches
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neurological symptom, Syncope
Clinical narrative: Fainting, blackouts,( stroke symptom of left  eye blackout) , fatigue, dizziness,  inability to focus , headaches
Age: 72.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 18.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, No adverse event, Product preparation issue
Clinical narrative: THE UNDILUTED PEDIATRIC DOSE WAS GIVEN TO THE PATIENT. WE CALLED MANUFACTURER AND WERE INFORMED THAT THE GIVEN DOSE WAS EQUIVALENT TO AN ADULT DOSE. PATIENT DID NOT REPORT ANY ADVERSE EFFECTS.
Age: 0.42
Sex: M
Vaccine: TDAP
Symptoms: Aphasia, Immunisation reaction
Clinical narrative: Stopped speaking, developed reaction, 3 years it took to undevelop some reactions
Age: 4.0
Sex: M
Vaccine: UNK
Symptoms: Aspiration bone marrow, Biopsy bone marrow, Contusion, Immune thrombocytopenia, Immunoglobulin therapy
Clinical narrative: Patient was given pentacel, hep B, rota and prevnar--3 days later had bruising and petechiae with plts of 4 consistent with ITP.
Age: 4.0
Sex: M
Vaccine: UNK
Symptoms: Laboratory test, Petechiae, Platelet count decreased
Clinical narrative: Patient was given pentacel, hep B, rota and prevnar--3 days later had bruising and petechiae with plts of 4 consistent with ITP.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac disorder, Catheter placement, Renal disorder, Respiratory distress
Clinical narrative: Cardiac distress Renal distress Respiratory distress Hospitalization, catheter for renal distress, oxygen for respiratory distress
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Aortic arteriosclerosis, Pain, Transient ischaemic attack
Clinical narrative: TRANSIENT CEREBRAL ISCHEMIA 4/22/2023 CHRONIC PAIN TRANSIENT CEREBRAL ISCHEMIA 4/22/2023 ATHEROSCLEROSIS OF AORTA
Age: 85.0
Sex: M
Vaccine: COVID19-2
Symptoms: Neuropathy peripheral
Clinical narrative: NEUROPATHY
Age: 5.0
Sex: F
Vaccine: DTAP
Symptoms: Expired product administered
Clinical narrative: Vaccine dose given past expire date of 3/1/2023
Age: 1.0
Sex: M
Vaccine: UNK
Symptoms: Incorrect dose administered
Clinical narrative: Patient was given varicella, full dose not administered, re-dose given same day.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Facial paresis
Clinical narrative: R29.810 LEFT FACIAL MUSCLE WEAKNESS 4/26/2023 RIGHT KNEE JOINT PAIN
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Imaging procedure abnormal
Clinical narrative: I95.9 HYPOTENSION 4/6/2023 ABNL ABDOMINAL IMAGING